source
- Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D dealAlnylam Pharmaceuticals announced its first discovery-focused AI deal Wednesday, tapping a Silicon Valley biotech startup to see if AI can boost its R&D efforts. Alnylam and Inceptive signed a coll…Endpoints · 1mo ago↗ source
- STAT+: Alnylam to partner with Inceptive Nucleics for AI foundation models for RNAi therapeuticsAlnylam announced a three-year deal with Inceptive, worth up to $2 billion, with $30 million up front in cash and equity in the startup.STAT · 1mo ago↗ source
- STAT+: HaloMD faces lawsuit alleging No Surprises Act middleman used ‘sham letter,’ misleading dataHighmark Health is the fourth insurer to sue HaloMD, seeking to overturn arbitration wins.STAT · 1mo ago